Most Popular Stories
Webinars
- Prepare Your Compliance Systems and Processes for the Physician Payments Sunshine ActBeginning in 2012, pharmaceutical, biotechnology and medical device companies will be requ
- Biomarkers and Translational Medicine in Early Phase Oncology Clinical Development (Part two of our three part series) Increasingly, new technologies are making it possible to carefully identify sets of patien
- Webinar: Next Gen Sequencing from FFPE SamplesNext generation sequencing (NGS) technologies hold enormous promise to advance personalize
- Getting the most out of First-in-Human and Early Clinical TrialsIn a follow-up to our webinar last month on first-in-human drug studies, FierceBiotech edi
Featured Jobs
-
District Sales Manager – Hematology, Denver / Phoenix Job
Celgene Corporation - Denver, CO, US -
Director Marketing Communications
Bailey Search & Associates - Boston, MA -
Manager, Business Development
Clinical Resource Network - Chicago, IL -
Director, Global Regulatory CMC Job
Celgene Corporation - Basking Ridge, NJ, US -
Facilities Project Manager
Genomics Institute of the Novartis Research Foundation - San Diego, CA
Events
- Live Web Conference: Risk Management of Adventitious Agent Contamination
March 21 - World Orphan Drug Congress USA 2012
10-13 April, 2012 — Gaylord National Resort and Convention Center, Washington, D.C. - Euro-Biotech Partnering Summit
May 30-June 1, 2012 — Paris, France - DCAT Week '12 Biologics Forum & Networking Reception
Mar 14 — New York City
Free Newsletter
FierceBiotech is the biotech industry's daily monitor, with a special focus on drug discovery and clinical trials. Keep up to speed with the latest biotechnology trends, breakthroughs and FDA approval news. Join 90,000+ biotechnology and pharma industry professionals who get FierceBiotech via daily email. Sign up today!
Popular Topics
Whitepapers
- Biosimilars: A Physician Perspective
- New MicroMass Study of Social Media Behavior Offers Connection Planning Insights for Healthcare Marketers
- Otava Lead-Like Library
- Retaining Brand Loyalty
- The 3W Gaurrantee: What you Really Saved when you invest in Outsourced Talent
- Social Media and Post-Marketing Drug Safety
Ventana CEO Christopher Gleeson
